| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Clinical Biology (L.L., T.I., J.-M.B.), Statistics (N.B.), Pathology (M.T., B.C.), Nuclear Medicine (M.S.), Commissariat à lEnergie Atomique-LRC29V, and Centre National de la Recherche Scientifique (CNRS)-UMR1582 (C.M.), Institut Gustave-Roussy, 94805 Villejuif Cedex, France; and Commissariat à lEnergie Atomique-LRC16V (T.P.), Université Nice Sophia-Antipolis, CNRS-UMR6078, F-06238 Villefranche-sur-Mer, France
Address all correspondence and requests for reprints to: Jean-Michel Bidart. Department of Clinical Biology, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. E-mail: bidart{at}igr.fr.
Iodide transport by thyrocytes involves two transporters, namely the Na+/I - symporter located at the basolateral pole and possibly pendrin in the apical membranes of the cell. Recently, we identified a human gene and its protein product, designated hAIT, as a putative new transporter involved in iodide transfer across the apical membrane of thyrocytes. In the present report, we analyzed both hAIT gene and protein expressions in a large series of benign and malignant human thyroid tissues.
Using immunohistochemistry, hAIT staining was detected in normal thyroid tissue in about 10% of follicles; in positive follicles, 1040% of thyrocytes, mostly the tall cells, were stained. In thyroid tissues obtained from patients with Graves disease and toxic adenomas, hAIT mRNA and protein levels were similar to those found in normal tissue. In hypofunctioning adenomas, hAIT mRNA levels were slightly decreased, and apical iodide transporter (AIT) immunostaining was similar to that observed in normal thyroid tissue. AIT staining was stronger in Hürthle cell adenomas and in microfollicular adenomas. In thyroid carcinomas, the mean and median hAIT mRNA levels were significantly decreased. Expression of AIT protein was undetectable in most papillary carcinomas and was weak but detectable in most follicular carcinomas; it was negative in anaplastic carcinomas.
This work was supported by grants from the Commissariat à lEnergie Atomique (CEA-LRC16V) and Electricité De France.
Abbreviations: AIT, Apical iodide transporter; Ct, threshold cycle; hAIT, human AIT; Mr, relative molecular mass; NIS, sodium/iodide symporter; PDS, Pendred syndrome.
This article has been cited by other articles:
![]() |
M. Xing Gene Methylation in Thyroid Tumorigenesis Endocrinology, March 1, 2007; 148(3): 948 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, S. Hu, P. Hou, D. Jiang, S. Condouris, and M. Xing Suppression of BRAF/MEK/MAP Kinase Pathway Restores Expression of Iodide-Metabolizing Genes in Thyroid Cells Expressing the V600E BRAF Mutant Clin. Cancer Res., February 15, 2007; 13(4): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Paroder, S. R. Spencer, M. Paroder, D. Arango, S. Schwartz Jr., J. M. Mariadason, L. H. Augenlicht, S. Eskandari, and N. Carrasco Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT PNAS, May 9, 2006; 103(19): 7270 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Jarzab, D Handkiewicz-Junak, and J Wloch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Jimenez, M. A. Zaballos, and P. Santisteban DARPP-32 (Dopamine and 3',5'-Cyclic Adenosine Monophosphate-Regulated Neuronal Phosphoprotein) Is Essential for the Maintenance of Thyroid Differentiation Mol. Endocrinol., December 1, 2005; 19(12): 3060 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bruno, E. Ferretti, E. Tosi, F. Arturi, P. Giannasio, T. Mattei, A. Scipioni, I. Presta, R. Morisi, A. Gulino, et al. Modulation of Thyroid-Specific Gene Expression in Normal and Nodular Human Thyroid Tissues from Adults: An in Vivo Effect of Thyrotropin J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5692 - 5697. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Porra, C. Ferraro-Peyret, C. Durand, S. Selmi-Ruby, H. Giroud, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, C. Bournaud, J. Orgiazzi, et al. Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations in Classical Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3028 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gopal, Y.-J. Fei, M. Sugawara, S. Miyauchi, L. Zhuang, P. Martin, S. B. Smith, P. D. Prasad, and V. Ganapathy Expression of slc5a8 in Kidney and Its Role in Na+-coupled Transport of Lactate J. Biol. Chem., October 22, 2004; 279(43): 44522 - 44532. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |